Clinical Trials Arena December 19, 2023
The life sciences sector is set to see a significant amount of change in 2024.
Significant regulatory changes across numerous medical fields are coming in 2024 with pharmaceutical and medical device companies urged to be ready for a year of legal alterations.
From the UK’s reworking of the Voluntary Scheme for Branded Medicines (VPAS) and delayed plans to introduce a new medical device validation scheme, to the United States’ attempt to regulate products that utilise artificial intelligence (AI), 2024 is set to be a busy year for healthcare regulators.
US – Regulating LDTs
Chief among US legal changes set to come into effect in 2024 that has raised concern is the Food and Drug Administration’s (FDA) plan to regulate laboratory-developed...
Today's Sponsors
Today's Sponsor